Replies to post #1177 on Geron Corp (GERN)

[maggco]

'rx7171'

I appreciate your comments, I’m just sorry that you haven’t the time to DD this company. You appear to be quite qualified to give some perspective on a company that has the potential to advance beyond GERN. Their propriety research derived from the University of Stanford and Nebraska has shown great advances in combining new large-molecule delivery technologies with biomedical agents shown to lengthen chromosomal telomeres in vitro, successful in vivo therapies might be developed that significantly offset, and potentially reverse many age-related diseases and address symptoms and signs recognized as human aging. Good luck with GERN, perhaps these two companies will be working together.